Stockholders' Equity - Schedule of Total Stock-Based Compensation Costs Incurred and Associated Tax Benefit Recognized (Details) - USD ($) $ in Thousands |
12 Months Ended | ||
|---|---|---|---|
Jun. 30, 2025 |
Jun. 30, 2024 |
Jun. 30, 2023 |
|
| Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
| Stock-based compensation costs | $ 91,661 | $ 80,184 | $ 71,142 |
| Tax benefit | (21,833) | (15,053) | (24,860) |
| Stock-based compensation costs, net of tax benefit | 69,828 | 65,131 | 46,282 |
| Cost of sales | |||
| Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
| Stock-based compensation costs | 8,945 | 7,563 | 6,465 |
| Selling, general and administrative expenses | |||
| Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
| Stock-based compensation costs | 64,588 | 58,149 | 53,049 |
| Research and development expenses | |||
| Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
| Stock-based compensation costs | $ 18,128 | $ 14,472 | $ 11,628 |